Home
SignalPath

SignalPath Market Share Analysis for April 2026

Verily Viewpoint Site CTMS (formerly SignalPath) is an advanced clinical trial management system that enables faster, higher-quality and more cost-effective research for enterprise research sites.

Industry: N/A

Domainsignalpath.com

Year Founded2014

Employees51 - 200

Annual Revenue$10M - $15M

SignalPath

SignalPath (including company regionals)

signalpath.com

See more website traffic and engagement information

SignalPath Revenue up to April 2026 is 10M - 15M

revenue generated by SignalPath top domains

SignalPath top domains revenue over 3 years

Revenue for SignalPath top domains

signalpath.com10M - 15M

See more with Sales Intelligence

Total visits to SignalPath's top domains

Understand SignalPath market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

signalpath.com1.3K

See more with Sales Intelligence

Avg. visit duration in SignalPath's top domains

Analyze SignalPath engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

signalpath.com00:00:35

See more with Sales Intelligence

Avg. pageviews on SignalPath's top domains

See how SignalPath keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

signalpath.com1.92

See more with Sales Intelligence

SignalPath top competitors by domain

Looks like there’s not enough data here

No Data to Display

Top technologies used by SignalPath

These are the website technologies, by industry, used by SignalPath top domains

Advertising (3)

DoubleClick

Email Services (3)

G Suite

eCommerce (2)

WooCommerce

Audio Video Media (1)

YouTube

More Technologies

10

See all

News & Signals from SignalPath

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAlphabet acquired Signalpath on Sep 1st '21.SignalPath provides Clinical Trial Management software to health systems and was acquired by Alphabet in September of 2021.

NewsSignalpath received financing of $18M in Series B on Jan 1st '19.SignalPath raised an $18 million Series B in 2019, which the company noted at the time was to be invested in new product and technology development and to grow its existing customer base.

NewsSignalpath launches suite of software products.Founded in 2014, SignalPath has created a suite of software products designed to improve efficiency for clinical research sites.